• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】42307

【品名】2-hydroxy-5-nitrobenzaldehyde;5-nitrosalicylaldehyde

【CA登记号】97-51-8

【 分 子 式 】C7H5NO4

【 分 子 量 】167.12104

【元素组成】C 50.31% H 3.02% N 8.38% O 38.29%

与该中间体有关的原料药合成路线共 4 条

合成路线1

该中间体在本合成路线中的序号:(I)

5-Nitrosalicylaldehyde (I) was condensed with diethyl bromomalonate (II) to give ethyl 5-nitrobenzofuran-2-carboxylate (III), which was converted into the corresponding primary amide (IV) by reaction with ethanolic ammonia. Dehydration of amide (IV) to the nitrile (V) was effected by treatment with POCl3. After formation of imidate (VI) with HCl/MeOH, cyclization with ethylenediamine produced the imidazoline (VII). The nitro group of (VII) was then reduced to amine (VIII) using Fe and HCl. This was finally converted to the title isothiocyanate by reaction with thiophosgene.

1 Hudson, A.L.; Nutt, D.J.; Grundt, P.; Coates, P.A.; Husbands, S.M.; Tyacke, R.; Robinson, E.S.J.; Lewis, J.W.; Probes for imidazole binding sites: Synthesis and evaluation of a selective, irreversible I2 ligand. Bioorg Med Chem Lett 2000, 10, 6, 605.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 42307 2-hydroxy-5-nitrobenzaldehyde;5-nitrosalicylaldehyde 97-51-8 C7H5NO4 详情 详情
(II) 35647 diethyl 2-bromomalonate 685-87-0 C7H11BrO4 详情 详情
(III) 42308 ethyl 5-nitro-1-benzofuran-2-carboxylate 69404-00-8 C11H9NO5 详情 详情
(IV) 42309 5-nitro-1-benzofuran-2-carboxamide C9H6N2O4 详情 详情
(V) 42310 5-nitro-1-benzofuran-2-carbonitrile C9H4N2O3 详情 详情
(VI) 42311 methyl 5-nitro-1-benzofuran-2-carboximidoate C10H8N2O4 详情 详情
(VII) 42312 2-(5-nitro-1-benzofuran-2-yl)-4,5-dihydro-1H-imidazole C11H9N3O3 详情 详情
(VIII) 42313 2-(4,5-dihydro-1H-imidazol-2-yl)-1-benzofuran-5-amine; 2-(4,5-dihydro-1H-imidazol-2-yl)-1-benzofuran-5-ylamine C11H11N3O 详情 详情

合成路线2

该中间体在本合成路线中的序号:(IV)

Coupling of decanoylchloride (I) with D-serine (II) under Schotten-Baumann conditions (with Na2CO3 in H2O/THF) provides N-decanoyl-D-serine (III). Separately, aldehyde (IV) is reduced by means of NaBH4 in EtOH to yield alcohol (V), whose nitro group is reduced by means of In and NH4Cl in EtOH to afford substituted aniline (VI). Coupling of 5-amino-2-hydroxybenzyl alcohol (VI) with serine (III) by means of dicyclohexylcarbodiimide (DCC) and 1-hydroxybenzotriazole (HOBt) in DMF furnishes compound (VII), which is finally oxidized with NaIO4 in MeOH/H2O to yield the desired spiroepoxide.

1 Giannis, A.; Arenz, C.; Synthesis of the first selective irreversible inhibitor of neutral sphingomyelinase. Angew Chem. Int Ed Engl 2000, 39, 8, 1440.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 28271 decanoyl chloride 112-13-0 C10H19ClO 详情 详情
(II) 15728 (+)-2-Amino-3-hydroxypropionic acid; D-(+)-Serine; D-serine 312-84-5 C3H7NO3 详情 详情
(III) 47198 (2R)-2-(decanoylamino)-3-hydroxypropionic acid C13H25NO4 详情 详情
(IV) 42307 2-hydroxy-5-nitrobenzaldehyde;5-nitrosalicylaldehyde 97-51-8 C7H5NO4 详情 详情
(V) 47199 2-(hydroxymethyl)-4-nitrophenol C7H7NO4 详情 详情
(VI) 47200 4-amino-2-(hydroxymethyl)phenol C7H9NO2 详情 详情
(VII) 47201 N-[(1R)-2-[4-hydroxy-3-(hydroxymethyl)anilino]-1-(hydroxymethyl)-2-oxoethyl]decanamide C20H32N2O5 详情 详情

合成路线3

该中间体在本合成路线中的序号:(V)

Coupling of N-Boc-phenylalanine (I) with amine (II) by means of HBTU and DIEA provides amide (III), whose Boc group is removed by treatment with HCl in dioxane to afford amine hydrochloride (IV). Finally, the target compound is obtained by reductive amination between amine (IV) and aldehyde (V) in MeOH in the presence of NaCNBH3.

1 Harriman, G.C.B.; Cochran, N.A.; Gallant, D.; Briskin, M.J.; Schwender, C.F.; Cell adhesion antagonists: Synthesis and evaluation of a novel series of phenylalanine based inhibitors. Bioorg Med Chem Lett 2000, 10, 14, 1497.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 12874 (2R)-2-[(tert-Butoxycarbonyl)amino]-3-phenylpropionic acid; N-alpha-t-BOC-L-Phenylalanine 13734-34-4 C14H19NO4 详情 详情
(II) 46226 isopentylamine; 3-methyl-1-butanamine C5H13N 详情 详情
(III) 46225 tert-butyl (1S)-1-benzyl-2-(isopentylamino)-2-oxoethylcarbamate C19H30N2O3 详情 详情
(IV) 46227 (2S)-2-amino-N-isopentyl-3-phenylpropanamide C14H22N2O 详情 详情
(V) 42307 2-hydroxy-5-nitrobenzaldehyde;5-nitrosalicylaldehyde 97-51-8 C7H5NO4 详情 详情

合成路线4

该中间体在本合成路线中的序号:(I)

O-Alkylation of 5-nitrosalicylaldehyde (I) with 1,2-dichloroethane (IIa) or 1-bromo-2-chloroethane (IIb) (3) by means of K2CO3 in DMF at 100-5 °c or 60 °c affords 2-(2-chloroethoxy)-5-nitrobenzaldehyde (III), which by reduction with nabH4 in THF or MeoH yields the corresponding alcohol (IV). O-Alkylation of alcohol (IV) with allyl bromide (V) and KoH and Bu4NHSo4 or Bu4Ni at 40 °c gives 2-(allyloxymethyl)-1-(2-chloroethoxy)-4-nitrobenzene (VI), which is then reduced with Fe in the presence of nH4cl in EtoH to yield the corresponding aniline (VII). condensation of amine (VII) with 4-[3-(allyloxymethyl)phenyl]-2-chloropyrimidine (VIII) by means of Hcl in buoH at 80 °c affords the 2-anilinopyrimidine derivative (IX), which then undergoes ring-closing metathesis in the presence of Grubbs’ second-generation catalyst and HCl in CH2Cl2 at 40-45 °c to yield macrocycle (X). Finally, compound (X) is submitted to microwave-assisted condensation with pyrrolidine (XI) in dimethylacetamide at 80 °c .
intermediate (VIII) can be prepared by Suzuki coupling of 2,4-dichloropyrimidine (XII) with 3-(hydroxymethyl)phenylboronic acid (XIII) in the presence of Pd(OAc)2, PPh3 and na2co3 in THF at 70 °c or Pd(PPh3)4 and Na2CO3 in DME at 80-5 °c to give [3-(2-chloropyrimidin-4-yl)phenyl]methanol (XIV), which is finally O-alkylated with allyl bromide (V) and KOH and Bu4NHSO4 or Cs2CO3 in DMF at 40 °c .

1 William, A.D., Lee, A.c., blanchard, S. et al. Discovery of the macrocycle 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene (SB1518), a potent Janus kinase 2/fms-like tyrosine kinase-3 (JAK2/FLT3) inhibitor for the treatment of myelofibrosis and lymphoma. J Med chem 2011, 54(13): 4638-58.
2 Lee, A., William, A., Poulsen, A. et al. Design, synthesis and SAR studies leading to SB1518, a novel macrocyclic JAK2/FLT3 inhibitor in phase 2 clinical trials for myelofibrosis and lymphoma. 102nd Annu Meet Am Assoc cancer Res (AAcR) (April 2-6, orlando) 2011, Abst 3564.
3 blanchard, S., Lee, c.H.A., nagaraj, H.K.M., Poulsen, A., Sun, E.t., tan, Y.L.E., William, A.D. (S*bio Pte. Ltd.). EP 1951729, JP 2009515954, US 8153632, Wo 2007058627.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(IIa) 16170 1,2-dichloroethane 107-06-2 C2H4Cl2 详情 详情
(IIb) 24271 1-bromo-2-chloroethane 107-04-0 C2H4BrCl 详情 详情
(IX) 68053 N-(3-((allyloxy)methyl)-4-(2-chloroethoxy)phenyl)-4-(3-((allyloxy)methyl)phenyl)pyrimidin-2-amine   C26H28ClN3O3 详情 详情
(I) 42307 2-hydroxy-5-nitrobenzaldehyde;5-nitrosalicylaldehyde 97-51-8 C7H5NO4 详情 详情
(III) 68048 2-(2-chloroethoxy)-5-nitrobenzaldehyde   C9H8ClNO4 详情 详情
(IV) 68049 (2-(2-chloroethoxy)-5-nitrophenyl)methanol   C9H10ClNO4 详情 详情
(V) 11463 3-Bromo-1-propene; 3-Bromopropene;allyl bromide 106-95-6 C3H5Br 详情 详情
(VI) 68050 2-((allyloxy)methyl)-1-(2-chloroethoxy)-4-nitrobenzene   C12H14ClNO4 详情 详情
(VII) 68051 3-((allyloxy)methyl)-4-(2-chloroethoxy)aniline   C12H16ClNO2 详情 详情
(VIII) 68052 4-[3-(allyloxymethyl)phenyl]-2-chloropyrimidine   C14H13ClN2O 详情 详情
(X) 68054     C24H24ClN3O3 详情 详情
(XI) 11376 Pyrrolidine 123-75-1 C4H9N 详情 详情
(XII) 54377 2,4-Dichloropyrimidine 3934-20-1 C4H2Cl2N2 详情 详情
(XIII) 68055 3-(hydroxymethyl)phenylboronic acid;(3-Hydroxymethyl)phenylboronic acid;(m-Hydroxymethyl)phenylboronic acid;3-Hydroxymethylbenzeneboronic acid 87199-15-3 C7H9BO3 详情 详情
(XIV) 68056 [3-(2-chloropyrimidin-4-yl)phenyl]methanol   C11H9ClN2O 详情 详情
Extended Information